SALT LAKE CITY, June 19, 2013 (GLOBE NEWSWIRE) -- ActiveCare, Inc. (OTCBB:ACAR), the service leader in disease and diabetes management, today announced Jonathan Olson as the Chief Technology Officer. Having served in key roles for Theradoc and Hospira, Olson brings extensive experience in the development and growth of unique and specialized service platforms in the healthcare industry. In addition to his technical experience, Olson has also been a contributing author in numerous peer-reviewed publications and holds two patents. "Jonathan is a proven technology leader. His innovation and vision will play a central role in the evolution of our technology and product platform," stated Michael Jones Chief Strategy Officer of ActiveCare.
Focused on the monitoring of chronic disease, ActiveCare recently launched the next generation of its web based solution for serving both patients and payers. Historically, disease management has been reactive, responding only when health issues resulted in hospitalizations or the magnitude of claims became noticeable. ActiveCare's unique approach gathers real-time biometric readings and associates them with claims data. Such a package of information is then routinely reported to the payers and their disease management partners. This methodology not only alerts disease management to patients with immediate health issues, but identifies those patients who fall into a high claims risk category before costly hospitalizations occur. This timely reporting allows for proactive care by disease managers preventing the costly medical claims that were the previous triggers to action. "The ActiveCare platform, with its real-time disease monitoring, has the potential to dramatically improve the health for millions of patients on a daily basis. This unique approach to some of the biggest problems that healthcare faces today promises to revolutionize the industry," stated Olson.
ActiveCare's technology and monitoring services are continuing to be refined and expanded to solve the demands of the healthcare industry. "Our solution brings real-time visibility to the management of diabetes and other chronic diseases. This visibility enables fundamental improvements in the treatment of diabetes and related diseases," concluded Jones.
ActiveCare, Inc. is the telehealth and personal emergency response solution leader. Headquartered in Salt Lake City, Utah, and publicly traded on the OTC Bulletin Board under symbol ACAR, ActiveCare is committed to providing consistent excellence in quality and safety, and friendly care for members and caregivers alike. To learn more about ActiveCare, Inc., visit the website at www.activecare.com or contact investor/media relations at 877-862-5545 or email@example.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, regulatory uncertainty and economic pressure on the healthcare industry in particular, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with assimilating our recent acquisitions. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.